E-LIB Suche - Ergebnisse für: Collée, J.M

1

161P Cancer risks for other sites in addition to breast in ..:

Schreurs, M.A.C. ; Schmidt, M.K. ; Hollestelle, A....
ESMO Open. 9 (2024) - p. 103183 , 2024

Link: https://doi.org/10.1016/..

2

Cancer risks for other sites in addition to breast in CHEK2..:

Schreurs, Maartje A.C. ; Schmidt, Marjanka K. ; Hollestelle, Antoinette...
Genetics in Medicine. , 2024

Link: https://doi.org/10.1016/..

3

TP53 germline mutation testing in early-onset breast cancer..:

Bakhuizen, J. J. ; Hogervorst, F. B. ; Velthuizen, M. E....
Familial Cancer. 18 (2019) 2 - p. 273-280 , 2019

Link: https://doi.org/10.1007/..

4

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy B..:

Heemskerk-Gerritsen, B. A. M. ; Seynaeve, C. ; van Asperen, C. J....
JNCI: Journal of the National Cancer Institute. 107 (2015) 5 - p. , 2015

Link: https://doi.org/10.1093/..

5

Timing of risk reducing mastectomy in breast cancer patient..:

Wevers, M. R. ; Schmidt, M. K. ; Engelhardt, E. G....
Familial Cancer. 14 (2015) 3 - p. 355-363 , 2015

Link: https://doi.org/10.1007/..

6

119 Efficacy of Bilateral Risk-reducing Mastectomy on Prima..:

Heemskerk-Gerritsen, A. ; Hooning, M. ; Tilanus-Linthorst, M.M.A....
European Journal of Cancer. 48 (2012) - p. S75 , 2012

Link: https://doi.org/10.1016/..

7

500 Is risk-reducing mastectomy in BRCA1/2 mutation carrier..:

Heemskerk-Gerritsen, B.A.M. ; Hooning, M.J. ; Jager, A....
European Journal of Cancer Supplements. 8 (2010) 3 - p. 206 , 2010

Link: https://doi.org/10.1016/..

8

Response to first line chemotherapy in BRCA1 and BRCA2 muta..:

Krieqe, M. ; Seynaeve, C. ; Meijers-Heijboer, H....
European Journal of Cancer Supplements. 6 (2008) 7 - p. 109 , 2008

Link: https://doi.org/10.1016/..

9

Human Uteroglobin Gene: Structure, Subchromosomal Localizat..:

ZHANG, ZHONGJIAN ; ZIMONJIC, DRAZEN B. ; POPESCU, NICHOLAS C....
DNA and Cell Biology. 16 (1997) 1 - p. 73-83 , 1997

Link: https://doi.org/10.1089/..

10

Number and sex of offspring of ΔF508 carriers outside cysti..:

de Vries, H. G. ; Collée, J. M. ; Meeuwsen, W. P...
Human Genetics. 95 (1995) 5 - p. 575-576 , 1995

Link: https://doi.org/10.1007/..

11

No clinical utility of KRAS variant rs61764370 for ovarian ..:

Hollestelle, A ; van der Baan, F.H ; Berchuck, A...
https://eprints.whiterose.ac.uk/86410/1/1-s2.0-S009082581500863X-main.pdf. , 2016

Link: https://eprints.whiteros..

12

Common genetic variants and modification of penetrance of B..:

Gaudet, M. M ; Kirchhoff, T ; Green, T...
PLoS Genetics, 2010, 6 (10), e1001183. , 2012

Link: http://hdl.handle.net/23..

13

Common alleles at 6q25.1 and 1p11.2 are associated with bre..:

Antoniou, A.C. (Antonis) ; Kartsonaki, C. (Christiana) ; Sinilnikova, O. (Olga)...
http://repub.eur.nl/pub/34038. , 2011

Link: http://repub.eur.nl/pub/..

14

Improved Overall Survival after Contralateral Risk-Reducing..:

AM Heemskerk-Gerritsen, Bernadette ; Rookus, Matti A ; Aalfs, Cora M...
International Journal of Cancer. , 2014

Link: https://doi.org/10.1002/..

15

The risk of primary and contralateral breast cancer after o..:

Vencken, Peggy M. L. H. ; Kriege, Mieke ; Hooning, Maartje...
Cancer. 119 (2012) 5 - p. 955-962 , 2012

Link: https://doi.org/10.1002/..